Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 2001 Dec;10(6):333–337. doi: 10.1080/09629350120102352

Suppressive effects of anti-allergic agent suplatast tosilate (IPD-1151T) on the expression of co-stimulatory molecules on mouse splenocytes in vivo.

M Kurokawa 1, K Kawazu 1, K Asano 1, K Fumio 1, A Mita 1, M Adachi 1
PMCID: PMC1781737  PMID: 11817674

Abstract

The effects of IPD-1151T on the expression of co-stimulatory molecules, CD40, CD80 and CD86, were investigated in vivo using mice with allergic disorders. BALB/c mice were immunized intraperitoneally with two doses of dinitrophenylated ovalbumin (DNP-OVA) at 1-week intervals. These mice then were treated intraperitoneally with 100 microg/kg of IPD-1151T once a day for 14 days, starting 7 days after the first immunization. On day 21, some mice were challenged intraperitoneally with DNP-OVA and the other mice were not challenged. All mice were autopsied on day 22 and assayed for immunoglobulin E, interleuken (IL)-4 and IL-5 productions following DNP-OVA immunization. The intraperitoneal treatment with IPD-1151T strongly suppressed immunoglobulin E contents in serum, which were enhanced by DNA-OVA immunization. IPD-1151T also caused a decrease in both IL-4 and IL-5 levels in splenic lymphocytes. We next examined the influence of IPD-1151T on co-stimulatory molecule expression on splenic lymphocytes. IPD-1151T caused suppression of CD40 and CD86 expression; however, the treatments did not affect CD80 expression.

Full Text

The Full Text of this article is available as a PDF (148.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chambers C. A., Allison J. P. Co-stimulation in T cell responses. Curr Opin Immunol. 1997 Jun;9(3):396–404. doi: 10.1016/s0952-7915(97)80087-8. [DOI] [PubMed] [Google Scholar]
  2. Harris N., Peach R., Naemura J., Linsley P. S., Le Gros G., Ronchese F. CD80 costimulation is essential for the induction of airway eosinophilia. J Exp Med. 1997 Jan 6;185(1):177–182. doi: 10.1084/jem.185.1.177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Hofer M. F., Jirapongsananuruk O., Trumble A. E., Leung D. Y. Upregulation of B7.2, but not B7.1, on B cells from patients with allergic asthma. J Allergy Clin Immunol. 1998 Jan;101(1 Pt 1):96–102. doi: 10.1016/S0091-6749(98)70199-X. [DOI] [PubMed] [Google Scholar]
  4. Jirapongsananuruk O., Hofer M. F., Trumble A. E., Norris D. A., Leung D. Y. Enhanced expression of B7.2 (CD86) in patients with atopic dermatitis: a potential role in the modulation of IgE synthesis. J Immunol. 1998 May 1;160(9):4622–4627. [PubMed] [Google Scholar]
  5. Koda A., Yanagihara Y., Matsuura N. IPD-1151T: a prototype drug for IgE antibody synthesis modulation. Agents Actions Suppl. 1991;34:369–378. [PubMed] [Google Scholar]
  6. Lenschow D. J., Walunas T. L., Bluestone J. A. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 1996;14:233–258. doi: 10.1146/annurev.immunol.14.1.233. [DOI] [PubMed] [Google Scholar]
  7. Mark D. A., Donovan C. E., De Sanctis G. T., Krinzman S. J., Kobzik L., Linsley P. S., Sayegh M. H., Lederer J., Perkins D. L., Finn P. W. Both CD80 and CD86 co-stimulatory molecules regulate allergic pulmonary inflammation. Int Immunol. 1998 Nov;10(11):1647–1655. doi: 10.1093/intimm/10.11.1647. [DOI] [PubMed] [Google Scholar]
  8. Nakada M., Nishizaki K., Yoshino T., Okano M., Masuda Y., Ohta N., Akagi T. CD86 (B7-2) antigen on B cells from atopic patients shows selective, antigen-specific upregulation. Allergy. 1998 May;53(5):527–531. doi: 10.1111/j.1398-9995.1998.tb04091.x. [DOI] [PubMed] [Google Scholar]
  9. Oda N., Minoguchi K., Yokoe T., Hashimoto T., Wada K., Miyamoto M., Tanaka A., Kohno Y., Adachi M. Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Life Sci. 1999;65(8):763–770. doi: 10.1016/s0024-3205(99)00303-3. [DOI] [PubMed] [Google Scholar]
  10. Robinson D. S. T cell costimulation: a potential therapeutic target in asthma? Clin Exp Allergy. 1998 Jul;28(7):788–790. doi: 10.1046/j.1365-2222.1998.00305.x. [DOI] [PubMed] [Google Scholar]
  11. Tsuyuki S., Tsuyuki J., Einsle K., Kopf M., Coyle A. J. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness. J Exp Med. 1997 May 5;185(9):1671–1679. doi: 10.1084/jem.185.9.1671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Van Neerven R. J., Van de Pol M. M., Van der Zee J. S., Stiekema F. E., De Boer M., Kapsenberg M. L. Requirement of CD28-CD86 costimulation for allergen-specific T cell proliferation and cytokine expression. Clin Exp Allergy. 1998 Jul;28(7):808–816. doi: 10.1046/j.1365-2222.1998.00306.x. [DOI] [PubMed] [Google Scholar]
  13. Weaver C. T., Unanue E. R. The costimulatory function of antigen-presenting cells. Immunol Today. 1990 Feb;11(2):49–55. doi: 10.1016/0167-5699(90)90018-5. [DOI] [PubMed] [Google Scholar]
  14. Worm M., Henz B. M. Molecular regulation of human IgE synthesis. J Mol Med (Berl) 1997 Jun;75(6):440–447. doi: 10.1007/s001090050129. [DOI] [PubMed] [Google Scholar]
  15. Yamaya H., Basaki Y., Togawa M., Kojima M., Kiniwa M., Matsuura N. Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents. Life Sci. 1995;56(19):1647–1654. doi: 10.1016/0024-3205(95)00132-p. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES